Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Consistency in both timing and accuracy matters greatly
The underlying drug in Mounjaro is a dual GIP and GLP-1 receptor agonist known as tirzepatide
Weekly Semaglutide Injections: The traditional and most widely used GLP-1 format
At its highest dose, tirzepatide achieves approximately 20-22% weight loss
Cost, Availability, and Access Pathways: Comparing Branded, Telehealth, and Compounded Semaglutide Access to semaglutide in 2026 reflects a multi-pathway landscape shaped by regulatory frameworks, supply considerations, and cost structures
It signals deep confidence in the platforms clinical model and medication efficacy, and it materially reduces the financial risk for patients who are investing in GLP-1 therapy for the first time
US$ 21.33
US$ 21.47
US$ 27.60
US$ 25.50
